医学
经皮冠状动脉介入治疗
支架
心脏病学
药物洗脱支架
临床终点
冠状动脉疾病
不利影响
内科学
裸金属支架
随机对照试验
外科
心肌梗塞
作者
Camila Correa-Sadouet,Alfredo M. Rodriguez‐Granillo,C Sosa Gallardo,Juan Mieres,Lucía Fontana,María Valeria Curotto,Pedro Wainer,Norberto G. Allende,Carlos Fernández‐Pereira,Héctor Vetulli,Ricardo Pérez de la Hoz,Adnan Kastrati,Alfredo E. Rodríguez,Orca investigators
出处
期刊:Future Cardiology
[Future Medicine]
日期:2021-07-01
卷期号:17 (4): 539-547
标识
DOI:10.2217/fca-2020-0161
摘要
The use of colchicine is associated with a significant reduction of cardiac adverse events in patients with coronary artery disease. Past small randomized trials with oral immunosuppressive or anti-inflammatory therapies have demonstrated a reduction of adverse clinical events after bare metal stent implantation. The potential role of adjunctive colchicine after bare-metal stent implantation, compared with drug-eluting stent alone, is unknown. The primary end point of the study will be to compare cost-effectiveness at 1 year of follow-up of coronary intervention with bare-metal stent implantation plus 1 mg of colchicine during 3 months versus percutaneous coronary intervention with drug-eluting stent implantation alone. ClinicalTrials.gov identifier: NCT04382443.
科研通智能强力驱动
Strongly Powered by AbleSci AI